Review
Open access
Jul 2026
Beyond EMT: Mesenchymal drift as an emerging driver of stromal-immune reprogramming in prostate cancer
By integrating diverse mesenchymal transition processes under a unified conceptual framework, this review positions mesenchymal drift as a unifying axis of stromal-immune reprogramming in prostate cancer and underscores its significance for next-generation therapeutic strategies.
Zijia Zhang, Feifan Liu, Shuze Liu et al.
· iScience · 0 citations